|
|
 Previous Article | Table of Contents | Next Article 
Fibrinolytic properties of a human endothelial hybrid cell line (Ea.hy 926)
JJ Emeis and CJ Edgell
Gaubius Institute TNO, Leiden, The Netherlands.
The fibrinolytic characteristics of the endothelial hybrid cell line EA.hy
926, established by fusing a human umbilical vein endothelial cell with a
human carcinoma cell line, were studied. The hybrid cell line produced
large amounts of tissue-type plasminogen activator (t- PA), plasminogen
activator inhibitor type 1, and a small amount of urokinase. All
plasminogen activator present in conditioned medium was complexed with
inhibitor because the cells secreted plasminogen activator inhibitor in
excess over plasminogen activator and no activator activity was detectable
in conditioned media by direct activity assays. t-PA activator activity
was, however, demonstrable in conditioned media after treatment with sodium
dodecyl sulfate, in agreement with t-PA antigen determinations. Increased
plasminogen activator inhibitor activity could be induced by incubating the
cells in the presence of endotoxin or microtubule inhibitors, whereas
increased t-PA activity could be induced by microtubule inhibitors.
Interleukin-1 had no effect. The fibrinolytic characteristics of the hybrid
cell line were stable for at least 30 passages. The perpetual human hybrid
cell line EA.hy 926 therefore may be a useful tool for the study of
fibrinolysis in cultured endothelial cells.
Volume 71,
Issue 6,
pp. 1669-1675,
06/01/1988
Copyright © 1988 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
Y. Suzuki, H. Mogami, H. Ihara, and T. Urano
Unique secretory dynamics of tissue plasminogen activator and its modulation by plasminogen activator inhibitor-1 in vascular endothelial cells
Blood,
January 8, 2009;
113(2):
470 - 478.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Bednarek, J. Boncela, K. Smolarczyk, A. Cierniewska-Cieslak, E. Wyroba, and C. S. Cierniewski
Ku80 as a Novel Receptor for Thymosin 4 That Mediates Its Intracellular Activity Different from G-actin Sequestering
J. Biol. Chem.,
January 18, 2008;
283(3):
1534 - 1544.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Boncela, K. Smolarczyk, E. Wyroba, and C. S. Cierniewski
Binding of PAI-1 to Endothelial Cells Stimulated by Thymosin beta4 and Modulation of Their Fibrinolytic Potential
J. Biol. Chem.,
January 13, 2006;
281(2):
1066 - 1072.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Al-Nedawi, J. Szemraj, and C. S. Cierniewski
Mast Cell-Derived Exosomes Activate Endothelial Cells to Secrete Plasminogen Activator Inhibitor Type 1
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2005;
25(8):
1744 - 1749.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. N. I. Al-Nedawi, M. Czyz, R. Bednarek, J. Szemraj, M. Swiatkowska, A. Cierniewska-Cieslak, J. Wyczolkowska, and C. S. Cierniewski
Thymosin {beta}4 induces the synthesis of plasminogen activator inhibitor 1 in cultured endothelial cells and increases its extracellular expression
Blood,
February 15, 2004;
103(4):
1319 - 1324.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Westmuckett, C. Lupu, S. Roquefeuil, T. Krausz, V. V. Kakkar, and F. Lupu
Fluid Flow Induces Upregulation of Synthesis and Release of Tissue Factor Pathway Inhibitor In Vitro
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2000;
20(11):
2474 - 2482.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Ziegler, P. Silacci, V. J. Harrison, and D. Hayoz
Nitric Oxide Synthase Expression in Endothelial Cells Exposed to Mechanical Forces
Hypertension,
August 1, 1998;
32(2):
351 - 355.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Carveth, M. K. Topham, E. B. Tarbet, T. M. Mcintyre, S. M. Prescott, and G. A. Zimmerman
Bacterial lipopolysaccharide induces endothelial cells to synthesize a degranulating factor for neutrophils
FASEB J,
June 1, 1998;
12(9):
673 - 684.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
L. Nelimarkka, V. Kainulainen, E. Schonherr, S. Moisander, M. Jortikka, M. Lammi, K. Elenius, M. Jalkanen, and H. Jarvelainen
Expression of Small Extracellular Chondroitin/Dermatan Sulfate Proteoglycans Is Differentially Regulated in Human Endothelial Cells
J. Biol. Chem.,
May 9, 1997;
272(19):
12730 - 12737.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Kainulainen, L. Nelimarkka, H. Jarvelainen, M. Laato, M. Jalkanen, and K. Elenius
Suppression of Syndecan-1 Expression in Endothelial Cells by Tumor Necrosis Factor-alpha
J. Biol. Chem.,
August 2, 1996;
271(31):
18759 - 18766.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
